Brand profile · Pharmaceutical Manufacturing

Argenta

Argenta is a Pharmaceutical Manufacturing brand in Auckland, New Zealand. Ownership is privately held; it publishes at argentaglobal.com. The record carries seven addresses across five office countries. The record counts 514 people. Tagged animal health, consultancy and technology transfer. Its latest round on record is Private equity, US$30.0M. It is listed alongside eight similar brands, mostly in Pharmaceutical Manufacturing.

Profile live Privately Held Founded 2006 5 office countries US$ 30.0M Private equity

Key facts

Counted staff
514
self-reported 501–1,000 band
Founded
2006
20 years
Legal entities
None matched
Office countries
5
7 addresses
Funding rounds
1
Private equity · Jun 2021 · US$ 30.0M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

At Argenta, we’ve been collaborating with clients worldwide since 2006, bringing expertise, innovation, and a can-do attitude to deliver cutting-edge animal health & nutrition, and human nutrition solutions.

Why Argenta?

We are the only global CRO and CDMO focused exclusively on animal health & nutrition, complemented by regulatory expertise in human nutrition. We provide tailored, end-to-end solutions from Molecule to Market at any scale.

Our Three Pillars:

  • Global Partnerships – turning ideas into reality worldwide
  • Molecule to Market Approach – guiding products from research to launch
  • Innovation – driving progress in animal & nutrition, and human nutrition

Our Services:

  • R&D: innovative animal health & nutrition solutions, fully EMA/FDA/EFSA compliant
  • Pre-Clinical Research: dedicated teams in Spain, Germany, and the US providing confident go/no-go decisions
  • Clinical Research: agile, high-quality veterinary studies delivered on time and within budget
  • GMP Manufacturing: facilities in New Zealand, the US, and the UK
  • Regulatory & Scientific Consultancy: expert support for medicinal products, feed additives, and human nutrition products (novel foods, food additives, enzymes, etc)
  • Full Product Development: from concept to market

Collaboration at Our Core:

950+ experts in science, veterinary, engineering, and regulatory affairs, working closely with clients to develop products that truly make an impact.

Our Story:

Founded in New Zealand by scientist Doug Cleverly, Argenta combines Kiwi ingenuity with global collaboration. Our roots as a trusted CRO go back to 1987, built on scientific excellence and long-term partnerships.

Today, through our CMO & CDMO facilities, we optimize efficacy trials, accelerate product development, and help companies turn innovative ideas into market-ready products.

We also support human nutrition projects, guiding companies through regulatory pathways to successfully launch new products.

Let’s make it happen - together!

Specialties

All 15 specialties
  • animal health
  • product development
  • veterinary pharma
  • contract manufacturing
  • contract research
  • research & development
  • innovation
  • technology transfer
  • regulatory services
  • clinical research
  • data management
  • pre-clinical research
  • consultancy
  • pre-clinical services
  • clinical services

Related specialties

Locations

5
Countries with an office address7 addresses on record
New ZealandprimaryGermanySpainUnited KingdomUnited States

Country footprint

Offices in 5 countriesCountry footprint: 5 countries, primary NZ. Codes: NZ, DE, ES, GB, US.5 countriesprimary NZNZDEESGBUS
Show as table · Offices in 5 countries
Offices in 5 countries
Countries5
Primary countryNZ

All codes: NZ DE ES GB US

Addresses

  • NZ2 Sterling Ave; Auckland, New Zealand 2243Primary
  • US141 E Riverside Drive; Fort Dodge, IA 50501
  • US2029 Becker Drive; Suite 227; Lawrence, KS 66047
  • GBKinnoull Road Dunsinane Industrial Estate; Dundee, Scotland DD2 3XR
  • ESPl. Ausias March 1; 4th Floor; Sant Cugat del Vallès, Barcelona 08195
  • ESKomentu Txiki Kalea, 28; Hondarribia, Basque Country 20280
  • DEGeyerspergerstraße 27 d; Munich, Bavaria 80689

Grid intelligence Members

Funding

Last round · 20 June 2021US$ 30.0MPrivate equity · investor: Novaquest Capital Management
Rounds1
Round typePrivate equity · venture round
Amount (USD)30,000,000
Stage rank6
Investors named1
Since last round4 yr 7 mo

Funding

1 funding roundFunding timeline. Latest round 20 Jun 2021: Private equity, US$ 30.0M.20062026Private equityUS$ 30.0M1 round
Show as table · 1 funding round
1 funding round
Rounds1
Axis2006 to 2026
Private equity · 20 Jun 2021US$ 30.0M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Argenta?

The record holds 514 counted staff profiles at January 2026, inside the self-reported 501–1,000 band.

Where does Argenta have offices?

Seven addresses on record across 5 countries. Primary: 2 Sterling Ave, Auckland, New Zealand 2243.

Has Argenta raised funding?

One round. Latest 20 June 2021: private equity, US$30,000,000, investor Novaquest Capital Management.

What does Argenta list as its specialties?

15 tags on the brand's own list, among them animal health, consultancy and technology transfer.

Which companies are listed alongside Argenta?

29 profiles list Argenta as a peer — 96th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. GMP Pharmaceuticals Ltd and Vitaco Group list it back.

What is Argenta's website?